Tuesday, May 28, 2019

Russian scientists have created a unique vaccine against tick-borne encephalitis

The drug, developed by scientists from the Maritime Territory, created from the individual antigens, rather than whole virus - analogs such drug in the world. To create a vaccine developers We used the extract of seaweed, and its animal tests given very good results.

 Russian scientists have created a unique vaccine against tick-borne encephalitis  encephalitis vaccine


  The authors of a unique development became a Fellow of the Department of Biochemistry, Microbiology and Biotechnology School of Natural Sciences FEFU. In addition to the extract of sea algae involved in the recipe drug against tick-borne encephalitis . Scientists also used the bioactive components of sea cucumber - marine animal the family of echinoderms. Among the medicinal properties of sea cucumber - the ability to strengthen the immune system, normalize the endocrine system to resist the appearance of neoplasms in the body.
 
  In their studies, Vaccine developers have set the task to create an effective immune-stimulating complex biokomponetov able to deal with a dangerous virus, but not toxic to organism. Such components as researchers found could be cholesterol, lipids, saponins.
"Cholesterol We left unchanged, phospholipids, glycolipids replaced by that isolated from marine algae, and saponins isolated from sea cucumber "- said Leading Specialist Andrew Mazeyka.

As the expert explained, vaccine against tick-borne encephalitis   long-developed in the world laboratories. However, they all are based on whole virus. The same case, experts decided to use genetic engineering techniques to create from individual antigens structure (adjuvant) which would be similar in structure virus and imitated infectious agents - such innovation quite unique.
 
  Subunit vaccine produced by coastal scientists, it has been tested on animals, and gave good immune response. At the same time, experts believe that drugs based on they created an adjuvant would act against other infectious diseases. And while talking about the trials of a drug in humans is still too early, there is reason I assume that it will soon be used in veterinary medicine. (READ MORE)


Industry News

Go back to the main page

No comments:

Post a Comment